The Europe Adhesion Barrier Market would witness market growth of 7.0% CAGR during the forecast period (2023-2030).
Adhesive diseases are a major source of concern and morbidity, particularly for patients with postoperative complications. As a result, surgeons strongly advise and utilize adhesion barriers to lower complications in various departments, including gynecology, general surgery, etc. Adhesion barriers are available in various forms, including gels, physical film/mesh, fabric, etc. They are essential in preventing post-surgical complications for patients.
Various surgical associations and hospitals have been focusing more on raising awareness about the formation of post-surgical adhesions and the accessibility of anti-adhesive products to manage these complications of the patients as knowledge and understanding of adhesions and the associated issues have increased. The market has expanded quickly due to these considerations.
Abdominal adhesion is a side effect of radiation therapy used to treat a variety of abdominal malignancies, including gynecological illnesses prostate, rectal, or lymphoproliferative disorders. Major companies like Baxter, Anika Therapeutics, Inc., and Sanofi use synergistic strategies for product manufacturing and distribution. The aging population with gynecological problems is predicted to grow the market for adhesion barriers.
According to a UN report on French aging policy, France, like other European countries, is experiencing continual and large growth in the number of senior people. In 2012, there were 15 million people in France who were over 60 years old. The population will reach 24 million by 2060. As the older population is more likely to develop conditions that may need surgical intervention, it is anticipated that the aging of the European population will provide growth opportunities.
The Germany market dominated the Europe Adhesion Barrier Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $78.2 million by 2030. The UK market is exhibiting a CAGR of 6.1% during (2023 - 2030). Additionally, The France market would experience a CAGR of 7.7% during (2023 - 2030).
Based on Application Area, the market is segmented into General/Abdominal Surgeries, Orthopedic Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Urological Surgeries, Neurological Surgeries, Reconstructive Surgeries, and Others. Based on Formulation, the market is segmented into Film Formulations, Gel Formulations, and Liquid Formulations. Based on Product, the market is segmented into Synthetic Products (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol, and Others), and Natural Products. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Adhesion Barrier Market is Projected to reach USD 1.2 Billion by 2030, at a CAGR of 7.2%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Sanofi S.A., Becton Dickinson and Company, Baxter International, Inc.(Hill-Rom Holdings, Inc.), Johnson & Johnson, Anika Therapeutic, Inc., FzioMed, Inc., MAST Biosurgery USA, Inc.(MAST Biosurgery AG), Innocoll Biotherapeutics N.A. Inc., Luna Innovations, Incorporated and Integra LifeSciences Holdings Corporation.
By Application Area
By Formulation
By Product
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
